Fosamax MDL Plaintiffs Reject Need For High Court Review Of Preemption Ruling

( May 13, 2025, 10:01 AM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court should deny a petition for certiorari in the long-running Fosamax femur fracture multidistrict litigation because the Third Circuit U.S. Court of Appeals “faithfully” applied precedent from the high court “to the facts of this case to find that federal law did not preempt state-law claims” when it reversed a decision that awarded a drug manufacturer summary judgment in 1,046 cases, the plaintiffs say in a May 12 brief....